Should heart failure with supranormal ejection fraction (EF) be considered separate from preserved ejection fraction? (Journal of the American Heart Association) In people with heart failure with ...
Please provide your email address to receive an email when new articles are posted on . The mortality benefit from dapagliflozin may extend to patients with HF with improved ejection fraction.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blocker use did not reduce risk for death or new MI ...
Prague, Czechia – 21 May 2023: Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilisation for worsening heart failure in patients with ...
Smith and colleagues [1] addressed the problem of determining the prognosis of heart failure patients with preserved ejection fraction (EF) and published their results in the Journal of the American ...
Presenter: Christopher Fellows, MD, Virginia Mason Medical Center (Seattle, Washington) on behalf of the PAVE Study Group: LV based Cardiac Stimulation Post AV Nodal Ablation E valuation The ...
The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...
Rayan Salih, MD, a third-year internal medicine resident with the Northeast Georgia Health System, who hopes to specialize in cardiology, presented the poster, “Double Trouble: Pregnancy Challenges in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results